In fact, a recent study demonstrated that MCR stimulation in 7 mo APP/PS1 mice reduces neurotoxic A1 subtype of reactive astrocyte, which represents the major astrocytic subtype that mediates astrocytic toxicity in AD (40). Here, APP is linked to Alzheimer disease.